Sign in

Private company

ProSomnus, Inc.

In its 2024 annual report the company says: “We are a medical technology company focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Our patented precision devices are engineered to create unique, consistent and predictable biomechanical advantages that lead to effective, comfortable, economical and patient preferred treatment outcomes for patients with OSA.”3 It is headquartered in Pleasanton, California.1

Last updated Oct 21, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersPleasanton, California1
  • Business address5675 Gibraltar Dr, Pleasanton, Ca 945882
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

We are a medical technology company focused on the development, manufacturing and marketing of precision intraoral medical devices, a novel non-invasive option for treating and managing patients with obstructive sleep apnea (OSA). Each ProSomnus precision intraoral device is personalized based on the anatomy and treatment plan for each patient. Our patented precision devices are engineered to create unique, consistent and predictable biomechanical advantages that lead to effective, comfortable, economical and patient preferred treatment outcomes for patients with OSA.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-69.1%Operating margin4
-87.1%Net margin4
42.6%Revenue growth, 20234
-$17.6MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue49¢$13.6M
  • Research and development17¢$4.8M
  • Other costs14¢$3.8M
  • Interest19¢$5.4M

Out of $27.7M in revenue.4 The company lost money this year.

Financial statements

Revenue54$27.7M in 2023+96% since 2021
0$10.0M$20.0M$30.0M2021: $14.1M$14.1M20212022: $19.4M$19.4M2022+38%2023: $27.7M$27.7M2023+43%
Gross profit5$10.3M in 2022+40% since 2021
0$5.0M$10.0M$15.0M2021: $7.3M$7.3M20212022: $10.3M$10.3M2022+40%
Operating income54-$19.1M in 2023+296% since 2021
-$20.0M-$15.0M-$10.0M-$5.0M02021: -$4.8M-$4.8M20212022: -$11.5M-$11.5M2022+138%2023: -$19.1M-$19.1M2023+67%
Net income54-$24.1M in 2023+303% since 2021
-$30.0M-$20.0M-$10.0M02021: -$6.0M-$6.0M20212022: -$7.1M-$7.1M2022+20%2023: -$24.1M-$24.1M2023+237%
Fiscal year2020202120222023
Revenue$14.1M5$19.4M4$27.7M4
Cost of revenue$6.8M5$9.1M4$13.6M4
Gross profit$7.3M5$10.3M5
Research and development$1.9M5$3.0M4$4.8M4
Operating expenses$12.1M5$21.7M5$46.8M4
Operating income-$4.8M5-$11.5M4-$19.1M4
Interest$3.2M5$6.1M4$5.4M4
Income before tax-$6.0M5-$7.1M5
Income tax$04$04
Net income-$6.0M5-$7.1M4-$24.1M4
Earnings per share-$1.515-$0.714-$1.494
Earnings per share (diluted)-$1.515-$0.714-$1.494
Shares (weighted, basic)4.0M shares510.0M shares416.2M shares4
Shares (weighted, diluted)4.0M shares510.0M shares416.2M shares4

Compare ProSomnus, Inc. with another company

Corporate structure

ProSomnus, Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ProSomnus, Inc.

  • ProSomnus, Inc. Pleasanton, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ProSomnus, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$6.1M4 Dec 31, 2023$4.6M4 Dec 31, 2022+32.5%
Accumulated depreciation$2.7M4 Dec 31, 2023$2.2M4 Dec 31, 2022+24.7%
Property and equipment, net$3.4M4 Dec 31, 2023$2.4M4 Dec 31, 2022+39.7%
Finance-lease assets$3.3M4 Dec 31, 2023$3.6M4 Dec 31, 2022−10.5%
Operating-lease assets (leased space)$5.1M4 Dec 31, 2023$5.6M4 Dec 31, 2022−10.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$6.4M4 Dec 31, 2023$15.9M4 Dec 31, 2022−60.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$2.0M4 Dec 31, 2023$640.0K4 Dec 31, 2022+218.6%
Raw materials$2.0M4 Dec 31, 2023$562.0K4 Dec 31, 2022+250.0%
Work in process$72.0K4 Dec 31, 2023$78.0K4 Dec 31, 2022−7.7%

Leadership

Who has led ProSomnus, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Len Liptak2022–2024

Chief financial officer

  1. Melinda Hungerman2022–2023
  2. Brian B. Dow2023–2024
2025
Board members and other officers (6)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorLeonard Liptak named Oct 2, 202316
  • Executive OfficerSung Kim named Oct 2, 202316
  • DirectorHeather Rider named Oct 2, 202316
  • DirectorWilliam Johnson named Oct 2, 202316

Former names

  • LAAA Merger Corp.Jun 29, 2022 to Nov 15, 20222

Timeline

  1. Jul 31, 20248-K Bankruptcy or receivership; Other events17
  2. Jun 27, 20248-K Regulation FD disclosure; Other events18
  3. Jun 6, 20248-K New debt or obligation; Regulation FD disclosure19
  4. May 16, 20248-K Results of operations20
  5. May 8, 20248-K Entered a material agreement; Bankruptcy or receivership; New debt or obligation21
  6. Apr 30, 20248-K Entered a material agreement; New debt or obligation; Listing notice or transfer22
  7. Apr 19, 20248-K Entered a material agreement; New debt or obligation; Unregistered sale of shares23
  8. Apr 18, 20248-K Listing notice or transfer24
  9. Mar 26, 20248-K Results of operations25
  10. Mar 22, 20248-K Listing notice or transfer26
  11. Feb 16, 20248-K Listing notice or transfer27
  12. Dec 11, 20238-K Executive or director change; Bylaws or fiscal year changed; Shareholder vote28
  13. Dec 6, 2022New chief executive Len Liptak becomes CEO8

Calendar

When it reported results

  1. May 16, 2024Reported quarterly or annual results20
  2. Mar 26, 2024Reported quarterly or annual results25
  3. Nov 9, 2023Reported quarterly or annual results29
  4. Aug 3, 2023Reported quarterly or annual results30
  5. Jul 6, 2023Reported quarterly or annual results31
  6. May 9, 2023Reported quarterly or annual results32
  7. Mar 30, 2023Reported quarterly or annual results33
  8. Feb 1, 2023Reported quarterly or annual results34

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

159 filings to the SEC since October 2021: 3 annual reports, 5 quarterly reports, 34 major events, 38 insider forms, 8 large holders, 1 private raises, 70 other. The latest 20:

  1. Nov 13, 2024SC 13G/A EDGAR
  2. Aug 7, 2024EFFECT EDGAR
  3. Aug 7, 2024EFFECT EDGAR
  4. Aug 5, 202415-12G EDGAR
  5. Aug 2, 2024S-8 POS EDGAR
  6. Aug 2, 2024S-8 POS EDGAR
  7. Aug 2, 2024POS AM EDGAR
  8. Aug 2, 2024POS AM EDGAR
  9. Jul 31, 202410-Q EDGAR
  10. Jul 31, 20248-K EDGAR
  11. Jun 27, 20248-K EDGAR
  12. Jun 6, 20248-K EDGAR
  13. May 20, 202410-Q EDGAR
  14. May 16, 20248-K EDGAR
  15. May 15, 2024NT 10-Q EDGAR
  16. May 8, 20248-K EDGAR
  17. Apr 30, 20248-K EDGAR
  18. Apr 29, 202410-K/A EDGAR
  19. Apr 19, 20248-K EDGAR
  20. Apr 18, 20248-K EDGAR

The 159 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$10.1M 2023–2023
Money received by yearMoney received by year, 2023–2023: $10.1M in all. Private raises (Form D) $10.1M.$0$5M$10M$15M2023 · Private raises (Form D): $10.1M2023
Figures by year
YearPrivate raises (Form D)Total
2023$10.1M$10.1M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Sep 20, 2023Raised $10.1 million in a private offering of securities16 Form D: $25 million offered in all Form D

SEC filer profile

How ProSomnus, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARProSomnus, Inc.1
  • CIK0001934064
  • Employer ID (EIN)88-29782161
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address5675 Gibraltar Dr, Pleasanton, CA 945881
  • Phone844-537-53371
  • Shares outstanding17,394,064 as of Jul 29, 20247
  • Public float$25.7M as of Jun 30, 202339
  • On EDGAR sinceJun 29, 20221
  • Filings160 in all: 8-K (33), 4 (21), 424B3 (14), 3 (13), CORRESP (11), UPLOAD (8), EFFECT (7), 10-Q (5)1
    All 33 form types

    POS AM (5), S-1/A (5), 3/A (4), S-4/A (3), SC 13G/A (3), 10-K (2), DEF 14A (2), PRE 14A (2), S-1 (2), S-8 (2), S-8 POS (2), SC 13D (2), SC 13G (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 8-A12B (1), 8-K/A (1), ARS (1), CERT (1), D (1), NT 10-K (1), NT 10-Q (1), S-4 (1), SC 13D/A (1)

  • Latest filingsAnnual report (10-K) Mar 27, 2024
    Quarterly report (10-Q) Jul 31, 2024
    Proxy statement (DEF 14A) Nov 15, 2023
    Latest 8-K (8-K) Jul 31, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39